1. Maris RW. Suicide. Lancet 2002;360:319-326. PMID:
12147388.
2. Mann JJ. The neurobiology of suicide. Nat Med 1998;4:25-30. PMID:
9427602.
3. Bourne HR, Bunney WE Jr, Colburn RW, Davis JM, Davis JN, Shaw DM, et al. Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. Lancet 1968;2:805-808. PMID:
4175606.
4. Shaw DM, Camps FE, Eccleston EG. 5-Hydroxytryptamine in the hind-brain of depressive suicides. Br J Psychiatry 1967;113:1407-1411. PMID:
6078496.
5. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 2000;57:729-738. PMID:
10920459.
6. Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Pandey SC, Pesold C, et al. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 2002;159:419-429. PMID:
11870006.
7. Arora RC, Meltzer HY. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 1989;146:730-736. PMID:
2729424.
9. Antypa N, Serretti A, Rujescu D. Serotonergic genes and suicide: a systematic review. Eur Neuropsychopharmacol 2013;23:1125-1142. PMID:
23742855.
10. Correa H, Duval F, Mokrani M, Bailey P, Tremeau F, Staner L, et al. Prolactin response to D-fenfluramine and suicidal behavior in depressed patients. Psychiatry Res 2000;93:189-199. PMID:
10760377.
11. Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G. Auditory-evoked potentials as indicator of brain serotonergic activity--first evidence in behaving cats. Biol Psychiatry 1997;41:1181-1195. PMID:
9171909.
12. Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993;33:173-187. PMID:
8383545.
13. Buchsbaum M, Silverman J. Stimulus intensity control and the cortical evoked response. Psychosom Med 1968;30:12-22. PMID:
5640282.
14. Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G. Auditory evoked potentials reflect serotonergic neuronal activity--a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 1999;21:710-716. PMID:
10633476.
15. Hegerl U, Gallinat J, Juckel G. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 2001;62:93-100. PMID:
11172876.
16. Strobel A, Debener S, Schmidt D, Hunnerkopf R, Lesch KP, Brocke B. Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential. Am J Med Genet B Neuropsychiatr Genet 2003;118B:41-47. PMID:
12627465.
18. Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Moller HJ. The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci 1998;248:96-103. PMID:
9684919.
19. Kim DH, Park YM. The association between suicidality and serotonergic dysfunction in depressed patients. J Affect Disord 2013;148:72-76. PMID:
23312213.
20. Uhl I, Illes F, Grassnickel V, Echterhoff S, Norra C, Juckel G. Loudness dependence of auditory evoked potentials (LDAEP) in clinical monitoring of suicidal patients with major depression: a pilot study. Eur Arch Psychiatry Clin Neurosci 2012;262:487-492. PMID:
22350533.
21. Juckel G, Hegerl U. Evoked potentials, serotonin, and suicidality. Pharmacopsychiatry 1994;27(Suppl 1):27-29. PMID:
7984696.
22. Park YM, Lee BH, Lee SH. The association between serum lipid levels, suicide ideation, and central serotonergic activity in patients with major depressive disorder. J Affect Disord 2014;159:62-65. PMID:
24679391.
23. Lee SH, Park YC, Yoon S, Kim JI, Hahn SW. Clinical implications of loudness dependence of auditory evoked potentials in patients with atypical depression. Prog Neuropsychopharmacol Biol Psychiatry 2014;54:7-12. PMID:
24865151.
24. Park YM, Lee BH, Um TH, Kim S. Serum BDNF levels in relation to illness severity, suicide attempts, and central serotonin activity in patients with major depressive disorder: a pilot study. PLoS One 2014;9:e91061PMID:
24663244.
25. Agren H, Osterberg B, Franzen O. Depression and somatosensory evoked potentials: II. Correlations between SEP and depressive phenomenology. Biol Psychiatry 1983;18:651-659. PMID:
6135458.
26. Chen TJ, Yu YW, Chen MC, Wang SY, Tsai SJ, Lee TW. Serotonin dysfunction and suicide attempts in major depressives: an auditory event-related potential study. Neuropsychobiology 2005;52:28-36. PMID:
15942261.
27. Min JA, Lee SH, Lee SY, Chae JH, Lee CU, Park YM, et al. Clinical characteristics associated with different strengths of loudness dependence of auditory evoked potentials (LDAEP) in major depressive disorder. Psychiatry Res 2012;200:374-381. PMID:
23021319.
28. Marsic A, Berman ME, Barry TD, McCloskey MS. The relationship between intentional self-injurious behavior and the loudness dependence of auditory evoked potential in research volunteers. J Clin Psychol 2015;71:250-257. PMID:
25327536.